市場調査レポート
商品コード
1552456

止血剤(止血材)の世界市場:2033年までの機会と戦略

Hemostats Global Market Opportunities And Strategies To 2033


出版日
ページ情報
英文 285 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
止血剤(止血材)の世界市場:2033年までの機会と戦略
出版日: 2024年09月05日
発行: The Business Research Company
ページ情報: 英文 285 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の止血剤(止血材)市場は2018年に27億8,087万米ドルと評価され、2023年までCAGR2.0%以上で成長しました。

外科手術の増加

外科的処置の増加は、実績期間中に止血剤(止血材)市場の成長を牽引しました。止血剤(止血材)製品は、心臓血管外科、整形外科、神経外科、一般外科など、多様な外科専門分野にわたって不可欠であり、市場全体の需要に大きく寄与しています。このような多様な外科手術の増加は、ヘルスケア環境における止血剤(止血材)のニーズの増加を直接的に後押ししています。例えば、2022年2月の米国顔面形成外科学会(AAFPRS)の報告書によると、2021年には140万件の外科手術と非外科手術が行われ、2020年と比較すると平均600件増加しています。したがって、外科手術の増加が止血剤(止血材)市場の成長を支えました。

目次

第1章 エグゼクティブサマリー

  • 止血剤(止血材)-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • 止血剤(止血材)市場定義とセグメンテーション
  • 市場セグメンテーション:製品別
    • 能動止血剤(止血材)
    • 受動止血剤(止血材)
    • 複合止血剤(止血材)
    • その他の製品
  • 市場セグメンテーション:形態別
    • マトリックスとゲルの止血剤(止血材)
    • シートとパッドの止血剤(止血材)
    • スポンジ止血剤(止血材)
    • 粉末止血剤
    • その他の形態
  • 市場セグメンテーション:用途別
    • 整形外科
    • 一般外科
    • 神経外科
    • 心臓血管外科
    • 再建手術
    • 婦人科手術
    • その他の用途

第7章 主要な市場動向

  • 止血パウダー技術の革新
  • 市場プレーヤー間の戦略的コラボレーションとパートナーシップ
  • 困難な出血シナリオに対応する最先端の止血ソリューション

第8章 止血剤市場:マクロ経済シナリオ

  • COVID-19の影響:止血剤(止血材)市場
  • ウクライナ戦争の影響:止血剤(止血材)市場
  • 高インフレの影響:止血剤(止血材)市場

第9章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績, 2018-2023
    • 市場促進要因2018-2023
    • 市場抑制要因2018-2023
  • 市場成長予測, 2023-2028, 2033F
    • 市場促進要因2023-2028
    • 市場抑制要因2023-2028

第10章 世界の止血剤(止血材)市場:セグメンテーション

  • 世界の止血剤(止血材)市場:製品別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の止血剤(止血材)市場:処方別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の止血剤(止血材)市場:用途別、実績と予測, 2018-2023, 2028F, 2033F

第11章 止血剤(止血材)市場:地域・国別分析

  • 世界の止血剤(止血材)市場:地域別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の止血剤(止血材)市場:国別、実績と予測, 2018-2023, 2028F, 2033F

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Integra LifeSciences Corporation
  • Johnson & Johnson
  • Stryker Corporation

第20章 競合ベンチマーキング

第21章 競合ダッシュボード

第22章 主要な合併と買収

  • AA Medical Acquired Surgical Product Solutions(SPS)
  • Hemostasis LLC Acquired Fiagon Medical Technologies
  • Ethicon Acquired GATT Technologies B.V
  • Baxter Acquired CryoLife
  • Teleflex Acquired Z-Medica

第23章 機会と戦略

  • 世界の止血剤(止血材)市場、2028:新たな機会を提供する国
  • 世界の止血剤(止血材)市場、2028:新たな機会を提供するセグメント
  • 世界の止血剤(止血材)市場、2028:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第24章 止血剤(止血材)市場:結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人々

第25章 付録

目次
Product Code: o&s1313

Hemostats are surgical devices used to control bleeding during surgical procedures, making them essential in the medical and healthcare industry. These devices work by promoting blood clotting at the site of a surgical incision, thereby preventing excessive blood loss and facilitating the healing process.

The hemostats market consists of sales, by entities (organizations, sole traders and partnerships), of hemostats tools or equipment that are utilized by surgeons and medical practitioners across a wide range of surgical fields, including but not limited to orthopedic, neurological, cardiovascular, reconstructive, gynecological and general surgeries, to reduce or suppress bleeding. They are often used in operating rooms, emergency rooms and other medical settings where bleeding control is critical.

The global hemostats market was valued at $2,780.87 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 2.0%.

Increase In Surgical Procedures

An increase in surgical procedures drove the growth of the hemostats market during the historic period. Hemostatic products are essential across diverse surgical specialties such as cardiovascular, orthopedic, neurosurgery and general surgery, contributing significantly to the overall market demand. The growth in these varied surgical procedures directly drives the increasing need for hemostats in healthcare settings. For instance, according to the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) report in February 2022, 1.4 million surgical and non-surgical procedures were done in 2021, on an average of 600 more procedures had increased when compared with 2020. Therefore, an increase in surgical procedures supported the growth of the hemostats market.

Innovation In Hemostatic Powder Technology

Major companies operating in the hemostats market are focused on advancing their new technologies and research and developments. New product lines ensure that surgeons have access to the right tools for effectively controlling bleeding across a wide range of surgical procedures, thereby optimizing patient care. For instance, in March 2023, Baxter, a US-based healthcare company, launched PERCLOT Absorbable Hemostatic Powder in the U.S. PERCLOT is a passive, absorbable hemostatic powder that is ready-to-use and designed for patients with intact coagulation to address mild bleeding. The launch of PERCLOT in the U.S. provides surgeons a full range of active and passive hemostatic products for bleeding control, helping to optimize care for their patients.

The global hemostats market is highly concentrated, with a few large players operating in the market. The top ten competitors in the market made up to 60.22% of the total market in 2023.

Hemostats Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global hemostats market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for hemostats? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The hemostats market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider hemostats market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by formulation and by application.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the hemostats market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by formulation and by application in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for hemostats providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Product: Active Hemostats; Passive Hemostats; Combination Hemostats; Other Products
  • 2) By Formulation: Matrix And Gel Hemostats; Sheet And Pad Hemostats; Sponge Hemostats; Powder Hemostats; Other Formulations
  • 3) By Application: Orthopedic Surgery; General Surgery; Neurological Surgery; Cardiovascular Surgery; Reconstructive Surgery; Gynecological Surgery; Other Applications
  • Companies Mentioned: Baxter International Inc.; B. Braun Melsungen AG; Integra LifeSciences Corporation; Johnson & Johnson Inc.; Stryker Corporation
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; hemostats indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Hemostats - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Hemostats Market Definition And Segmentations
  • 6.4 Market Segmentation By Product
    • 6.4.1 Active Hemostats
    • 6.4.2 Passive Hemostats
    • 6.4.3 Combination Hemostats
    • 6.4.4 Other Products
  • 6.5 Market Segmentation By Formulation
    • 6.5.1 Matrix And Gel Hemostats
    • 6.5.2 Sheet And Pad Hemostats
    • 6.5.3 Sponge Hemostats
    • 6.5.4 Powder Hemostats
    • 6.5.5 Other Formulations
  • 6.6 Market Segmentation By Application
    • 6.6.1 Orthopedic Surgery
    • 6.6.2 General Surgery
    • 6.6.3 Neurological Surgery
    • 6.6.4 Cardiovascular Surgery
    • 6.6.5 Reconstructive Surgery
    • 6.6.6 Gynecological Surgery
    • 6.6.7 Other Applications

7 Major Market Trends

  • 7.1 Innovation In Hemostatic Powder Technology
  • 7.2 Strategic Collaborations And Partnerships Among Market Players
  • 7.3 Cutting-Edge Hemostat Solutions For Challenging Bleeding Scenarios

8 Hemostats Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On The Hemostats Market
  • 8.2 Impact Of The War In Ukraine On The Hemostats Market
  • 8.3 Impact Of High Inflation On The Hemostats Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Hemostats Market Segmentation

  • 10.1 Global Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Hemostats Market, Regional and Country Analysis

  • 11.1 Global Hemostats Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Hemostats Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate Tax Structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Asia-Pacific Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.6 Asia-Pacific Hemostats Market: Country Analysis
  • 12.7 China Market
  • 12.8 Summary
  • 12.9 Market Overview
    • 12.9.1 Country Information
    • 12.9.2 Market Information
    • 12.9.3 Background Information
    • 12.9.4 Government Initiatives
    • 12.9.5 Regulations
    • 12.9.6 Regulatory Bodies
    • 12.9.7 Major Associations
    • 12.9.8 Taxes Levied
    • 12.9.9 Corporate Tax Structure
    • 12.9.10 Major Companies
  • 12.10 China Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 China Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.12 China Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Market
  • 12.14 India Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 India Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.16 India Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Market
  • 12.18 Japan Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Japan Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.20 Japan Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Market
  • 12.22 Australia Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Australia Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.24 Australia Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Market
  • 12.26 Indonesia Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 Indonesia Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.28 Indonesia Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Market
  • 12.30 South Korea Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.31 South Korea Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.32 South Korea Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Investments
    • 13.2.11 Major Companies
  • 13.3 Western Europe Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.6 Western Europe Hemostats Market: Country Analysis
  • 13.7 UK Market
  • 13.8 UK Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 UK Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.11 Germany Market
  • 13.12 Germany Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 Germany Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.15 France Market
  • 13.16 France Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 France Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.19 Italy Market
  • 13.20 Italy Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Italy Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.23 Spain Market
  • 13.24 Spain Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.26 Spain Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Major Companies
  • 14.3 Eastern Europe Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.6 Eastern Europe Hemostats Market: Country Analysis
  • 14.7 Russia Market
  • 14.8 Russia Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.10 Russia Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Investments
    • 15.2.11 Major Companies
  • 15.3 North America Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.6 North America Hemostats Market: Country Analysis
  • 15.7 USA Market
  • 15.8 Summary
  • 15.9 Market Overview
    • 15.9.1 Country Information
    • 15.9.2 Market Information
    • 15.9.3 Background Information
    • 15.9.4 Government Initiatives
    • 15.9.5 Regulations
    • 15.9.6 Regulatory Bodies
    • 15.9.7 Major Associations
    • 15.9.8 Taxes Levied
    • 15.9.9 Corporate Tax Structure
    • 15.9.10 Investments
    • 15.9.11 Major Companies
  • 15.10 USA Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 USA Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.12 USA Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Market
  • 15.14 Canada Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.15 Canada Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.16 Canada Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Regulations
    • 16.2.5 Regulatory Bodies
    • 16.2.6 Major Associations
    • 16.2.7 Taxes Levied
    • 16.2.8 Corporate Tax Structure
    • 16.2.9 Major Companies
  • 16.3 South America Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.6 South America Hemostats Market: Country Analysis
  • 16.7 Brazil Market
  • 16.8 Brazil Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.10 Brazil Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Investments
    • 17.2.11 Major Companies
  • 17.3 Middle East Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.5 Middle East Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
  • 18.2 Market Overview
    • 18.2.1 Region Information
    • 18.2.2 Market Information
    • 18.2.3 Background Information
    • 18.2.4 Government Initiatives
    • 18.2.5 Regulations
    • 18.2.6 Regulatory Bodies
    • 18.2.7 Major Associations
    • 18.2.8 Taxes Levied
    • 18.2.9 Corporate Tax Structure
    • 18.2.10 Investments
    • 18.2.11 Major Companies
  • 18.3 Africa Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.5 Africa Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Baxter International Inc.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial Overview
  • 19.3 B. Braun Melsungen AG
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 Integra LifeSciences Corporation
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 Johnson & Johnson
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 Stryker Corporation
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 AA Medical Acquired Surgical Product Solutions (SPS)
  • 22.2 Hemostasis LLC Acquired Fiagon Medical Technologies
  • 22.3 Ethicon Acquired GATT Technologies B.V
  • 22.4 Baxter Acquired CryoLife
  • 22.5 Teleflex Acquired Z-Medica

23 Opportunities And Strategies

  • 23.1 Global Hemostats Market In 2028 - Countries Offering Most New Opportunities
  • 23.2 Global Hemostats Market In 2028 - Segments Offering Most New Opportunities
  • 23.3 Global Hemostats Market In 2028 - Growth Strategies
    • 23.3.1 Market Trend Based Strategies
    • 23.3.2 Competitor Strategies

24 Hemostats Market, Conclusions And Recommendations

  • 24.1 Conclusions
  • 24.2 Recommendations
    • 24.2.1 Product
    • 24.2.2 Place
    • 24.2.3 Price
    • 24.2.4 Promotion
    • 24.2.5 People

25 Appendix

  • 25.1 Geographies Covered
  • 25.2 Market Data Sources
  • 25.3 Research Methodology
  • 25.4 Currencies
  • 25.5 The Business Research Company
  • 25.6 Copyright and Disclaimer